Today plant-based gut health brand Biomel announced a £5.5 million investment from IRIS Ventures. Founded in 2017, the company is a UK market leader in plant-based gut health and produces a range of drinks, snack bars and powders from its manufacturing facility in West London.
The brand is stocked in major retailers, including M&S, Waitrose, Sainsbury's and Whole Foods Market, alongside a growing footprint in leading independent retailers and international markets.
This investment will used to accelerate Biomel's mission and expand capacity at its manufacturing facility.
Steven Hegarty, Co-founder and CEO, shares:
"Biomel was born out of our own desire to live healthier and more fulfilling lives and is based on the premise that your gut is at the heart of your health. Gut health affects everything from digestive to mental health through the gut-brain axis.
In fact, 70 percent of serotonin, the happy neurotransmitter and hormone, is produced in the gut."
"We have developed proprietary IP to bring differentiated and better solutions for consumers looking to improve their health and well-being through next-generation probiotic and prebiotic solutions that support digestive and immune health."
Montse Suarez, Founder and Managing Partner of IRIS Ventures, remarks:
"Backing Biomel's founders aligns perfectly with our mandate to empower a new generation of extraordinary visionaries.
They are the clear trailblazers in the plant-based gut health category with a refreshing and contemporary brand proposition that resonates with the modern consumer."